Live Breaking News & Updates on Polypeptide

Stay updated with breaking news from Polypeptide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Is Now An Opportune Moment To Examine PolyPeptide Group AG (VTX:PPGN)?

PolyPeptide Group AG ( VTX:PPGN ), might not be a large cap stock, but it received a lot of attention from a. ....

Polypeptide Group , Share Price , Ubstantial Price Increase ,

PolyPeptide Group First Half 2023 Earnings: Beats Expectations

PolyPeptide Group ( VTX:PPGN ) First Half 2023 Results Key Financial Results Revenue: €131.8m (down 1.4% from 1H 2022. ....

Polypeptide Group , Life Sciences , Polypeptide Group Revenues , Peptide Group Revenues , Earnings Beat , Earnings Per Share , Revenue Growth ,

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO - adhoc - Börsennachrichten

PolyPeptide Group Key word Half Year Results Transformational progress taking shape profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO 15Aug2023 0700 CETCEST Release ....

Marc Augustin , Lalit Ahluwalia , Peter Wilden , Thyssen Krupp , Polypeptide Group , Contract Development Manufacturing Organization , Heinrich Heine University In Dusseldorf , Switzerland European Shared Services , Master Of Business Administration , Swiss Exchange , Draupnir Holding , Polypeptide Results Center , Head Of Investor Relations Corporate Communications , Executive Committee , Vice President Finance , Global Head Sales Excellence , Lonza Biologics , Nephew Orthopaedics , Finance Operations Orthopaedics , Finance Director Switzerland , European Shared , Alcoa Extrusion , Business Administration , Heinrich Heine University , Executive Chairman , Peptide Group ,

PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 - adhoc - Börsennachrichten

PolyPeptide Group Key word Profit Warning PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 13Jul2023 0700 CETCEST Release of an ad hoc announ ....

Lalit Ahluwalia , Head Of Investor Relations Corporate Communications , Swiss Exchange , Polypeptide Group , Contract Development Manufacturing Organization , Media Release , Half Year Report , Corporate Website , Investor Relations , Contract Development , Manufacturing Organization ,

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs

PolyPeptide Group

/ Key word: Partnership

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs. | May 9, 2023 ....

Christian Schwarz , Numaferm Gmb , Olivier Ludemann Hombourger , Christopher Klein , Head Of Investor Relations Corporate Communications , Swiss Exchange , Polypeptide Group , Contract Development Manufacturing Organization , Preferred Partner Collaboration Agreement , Director Global Innovation , Green Chemistry , Contract Development , Manufacturing Organization , Investor Relations , Managing Director , Polypeptide Group Ag Stock Exchange , Press Release , F Ppgn Ch1110760852 ,